Luca Science

Developer of functional mitochondrial therapeutic agents by using drug delivery and formulation technology

placeChuo City, Tokyo, Japan calendar_todayFounded 2018 groups14 employees language luca-science.com

Social engagement

Social engagement: 610 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Axil Capital, Daiwa Corporate Investment, 4Bio Capital, FTI.

Investor typeCountShare
Venture capital1071%
Private equity17%
Other / undisclosed321%

Recent activity

20 Feb 2026
Product launch
MRC-Q
Coming soon